Details

Guidance Policy - Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research Policy (POL-0053) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 6, 2026 · edition #6
Timestamp: 2026-01-06T23:09:30.362Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-6/20260106230930/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=true#ha_snapshot=484176
ID: 484176
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots